« Back to Record
Piccart-Gebhart, M., Bertelsen, K., Stuart, G., Cassidy, J., Mangioni, C., Simonsen, E., James, K., Kaye, S., Vergote, I., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K., Trope, C., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. A., Lhoas, F., Lidvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Pecorelli, S., Baron, B., & Mcguire, W. P. (2003). Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. International journal of gynecological cancer, 13 Suppl 2, 144-148.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55783



